NovaQuest Pharma Opportunities Fund III, L.P. SEC EDGAR Filings (CIK 0001506260)

SEC EDGAR filings, ownership reports, and insider transactions for NovaQuest Pharma Opportunities Fund III, L.P..

Business address
4208 Six Forks Road, Suite 920, Raleigh, NC, 27609
State of incorporation
Cayman Islands
Fiscal year end
31 December
Former names
NovaQuest Healthcare Investment Fund III, L.P. (to 07 Oct 2011), NovaQuest Healthcare Investment Fund, L.P. (to 24 Nov 2010)
⭐ Add to watchlist ⭐
NovaQuest Pharma Opportunities Fund III, L.P. has filed 28 SEC EDGAR filings since 24 Nov 2010

Latest Filings

Recent SEC filings for NovaQuest Pharma Opportunities Fund III, L.P. including 13F-NT, SC 13G/A, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
13F-NT Open 13F-NT document View SEC filing for 13F-NT 25 Oct 2019 30 Sep 2019 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 29 Jul 2019 30 Jun 2019 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 08 May 2019 31 Mar 2019 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Feb 2019 31 Dec 2018 028-16648
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 12 Feb 2019
13F-NT Open 13F-NT document View SEC filing for 13F-NT 07 Nov 2018 30 Sep 2018 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 02 Aug 2018 30 Jun 2018 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 24 Apr 2018 31 Mar 2018 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 13 Feb 2018 31 Dec 2017 028-16648
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 08 Feb 2017
13F-NT Open 13F-NT document View SEC filing for 13F-NT 27 Oct 2016 30 Sep 2016 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 26 Jul 2016 30 Jun 2016 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 25 Apr 2016 31 Mar 2016 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 09 Feb 2016 31 Dec 2015 028-16648
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 09 Feb 2016
13F-NT Open 13F-NT document View SEC filing for 13F-NT 13 Oct 2015 30 Sep 2015 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 03 Aug 2015 30 Jun 2015 028-16648
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 27 May 2015 07 May 2015 001-36297
13F-NT Open 13F-NT document View SEC filing for 13F-NT 28 Apr 2015 31 Mar 2015 028-16648
13F-NT Open 13F-NT document View SEC filing for 13F-NT 17 Feb 2015 31 Dec 2014 028-16648
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 17 Feb 2015
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Apr 2014 08 Apr 2014 001-36297
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Feb 2014 11 Feb 2014 001-36297
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 05 Feb 2014 05 Feb 2014 001-36297
D/A Open D/A document View SEC filing for D/A 14 Nov 2012 021-150993
D/A Open D/A document View SEC filing for D/A 05 Jan 2012 021-150993
D/A Open D/A document View SEC filing for D/A 07 Oct 2011 021-150993
D Open D document View SEC filing for D 24 Nov 2010 021-150993

About this filer

NovaQuest Pharma Opportunities Fund III, L.P. files with the SEC under CIK 0001506260. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages